MODERNA Covid-19 vaccine secures European approval
Moderna Inc has been granted conditional marketing authorisation for its Covid-19 vaccination by the European Medicines Agency (EMA) on Wednesday, January 6. It is set to become the second vaccine approved after the Pfizer jab got the go-ahead on December 21. The Moderna coronavirus vaccine still requires approval from the European Commission which is expected to happen later on Wednesday, according to Reuters.
📢 EMA has recommended granting a conditional marketing authorisation for COVID-19 Vaccine Moderna to prevent #COVID19 in people from 18 years of age: https://t.co/l9KMZlx7wa pic.twitter.com/BdvXanjOHN
— EU Medicines Agency (@EMA_News) January 6, 2021
Experts say that the Moderna jab will be easier to rollout as it doesn’t require storage at extremely low temperatures like the Pfizer/BioNtech vaccine, but instead can be kept at a reasonable -20C.
Thank you for taking the time to read this news article “Moderna Vaccine Secures European Approval”. For more UK daily news, Spanish daily news and Global news stories, visit the Euro Weekly News home page.